$AMGN
看空2022-09-12各周期结果✓ 命中-0.9%
1d
…
5d
✓ -3.8%
21d
✓ -0.9%
原帖
Andy Biotech · 2022-09-12
#ESMO22 $AMGN Lumakras very underwhelming Codebreak-200 data on top of an already slow launch How to justify $18K/mo price w/ ~1mo mPFS benefit and detrimental overall survival? Double whammy day w/ $BMY Sotyktu clean label re. Otezla. Silver lining: more need for SMID bio M&A? https://t.co/yUJzraVg36
在 X 查看 ↗